U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923214) titled 'A Phase I Study of CG-7321 Monotherapy or Combination Therapy in Advanced Solid Tumors' on O... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923799) titled 'Protocol in Musician's Focal Dystonia (MISA)' on Aug. 31. Brief Summary: Musician's Focal D... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07921329) titled 'Nightly Wearable Monitoring During Home-Based Submental Electrical Stimulation for Obstructi... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07921680) titled 'Influence of Patient Positioning During Nasal Lavage' on Oct. 23. Brief Summary: Acute uppe... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07922343) titled 'Virtual Reality's Impact on Reducing Pain During Episiotomy Repair' on June 13, 2025. Brief... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923448) titled 'Can TrenibotulinumtoxinE Reverse OnabotulinumtoxinA Effect in Treating Lateral Canthal Lines... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923474) titled 'Virtual Reality Multidomain Training for Older Adults With Cognitive Frailty' on Nov. 02. B... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923773) titled 'Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07922070) titled 'A Bioequivalence Study of Olanzapine Samidofen Tablets in Healthy Subjects Under Fasting Con... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07920731) titled 'A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancre... Read More